Financing of vaccine delivery in primary care practicesPrimary care practices are the backbone of childhood immunization delivery, and have become indispensable in the promotion of public health. Over the last decades, however, the skyrocketing costs of vaccines have gone from a minor consideration in the overhead of a pediatric practice to one of significant financial burden, largely because of new vaccines.
7 Tips to pricing cosmetic proceduresExperts say these procedure pricing tips will help to promote the financial health of the practice, avoid commoditization and boost professional satisfaction.
Four ways to adopt a capabilities-driven strategy in the new health economyAs pharmaceutical companies of all sizes continue to adapt to the ongoing internal and external pressures of the new health economy, it remains imperative that strategy maintain distinct capabilities to position the company ahead of its competitors.
Cutting costs to help your practice thriveWith reimbursement changes coming, practices need to watch every penny
Premium Content Preview | 5 Ways to save your hospital money with better communicationsIn this eBrief we look at why increasing the efficiency of critical test results management (CTRM) is of vital importance for your organization and your patients.
The tale of the $220 tube of clobetasol creamThe economic realities of increased prices for medications strikes at the heart of the services that dermatologists provide for patients.
Prior auths are here to stayWe asked healthcare experts and analysts how the move to value-based care will affect prior authorizations. Here's what they said.
New York law sets standard for transparencyA new healthcare cost transparency law in New York State created to protect consumers requires insurers to publish clear information about health plan rules.
A properly designed compounding benefit can help control costs and qualityA properly designed compounding benefit that works with industry providers is more effective at controlling costs and quality than a negative approach that can limit patient care and potentially increase costs.
Increasing regulations could raise managed drug plan costsIncreasing unnecessary regulations on drug plans could inflict higher costs on the 220 million Americans who get their medications through a managed drug plan, according to a new report.